7Baggers
Quarterly
Annual
    Unit: USD2025-06-29 2025-03-30 2024-12-29 2024-09-29 2024-06-30 2024-03-31 2023-12-31 2023-10-01 2023-07-02 2023-04-02 
      
    		          
      cash flows from operating activities
    		          
      net income
    		420,000,000 322,000,000 293,000,000 383,000,000 58,000,000 296,000,000 327,000,000 577,000,000 430,000,000 330,000,000 
      adjustments to reconcile net income to cash flows from operating activities
    		          
      depreciation and amortization
    		142,000,000 136,000,000 150,000,000 182,000,000 141,000,000 149,000,000 174,000,000 153,000,000 148,000,000 152,000,000 
      stock-based compensation
    		37,000,000 44,000,000 54,000,000 58,000,000 61,000,000 81,000,000 113,000,000 2,000,000 38,000,000 35,000,000 
      deferred income taxes
    		-14,000,000 -13,000,000 -40,000,000 -40,000,000 -201,000,000 -4,000,000 14,000,000 -283,000,000 -12,000,000 167,000,000 
      impairment charges
    		  0 0       
      losses on investments
    		          
      other
    		17,000,000 16,000,000 2,000,000 17,000,000 45,000,000 5,000,000 17,000,000 -23,000,000   
      net changes in assets and liabilities
    		          
      trade receivables
    		48,000,000 -99,000,000 125,000,000 -110,000,000 -109,000,000 -124,000,000 141,000,000 -42,000,000 -78,000,000 23,000,000 
      inventories
    		-51,000,000 -66,000,000 169,000,000 62,000,000 14,000,000 -63,000,000 74,000,000 132,000,000 126,000,000 17,000,000 
      other current and non-current assets
    		53,000,000 59,000,000 -46,000,000 -6,000,000 90,000,000 -55,000,000 -11,000,000 77,000,000 -482,000,000 -13,000,000 
      accounts payable and accrued liabilities
    		123,000,000 -14,000,000 37,000,000 -336,000,000 -56,000,000 -181,000,000     
      employee-related obligations
    		-7,000,000 3,000,000         
      accrued taxes on income
    		-91,000,000 62,000,000 -70,000,000 53,000,000 -71,000,000 27,000,000   -479,000,000 272,000,000 
      other liabilities
    		-56,000,000 -22,000,000 25,000,000 -12,000,000 -13,000,000 52,000,000 11,000,000 28,000,000 -62,000,000 -189,000,000 
      net cash flows from operating activities
    		621,000,000 428,000,000 793,000,000 249,000,000 440,000,000 287,000,000 950,000,000 674,000,000 742,000,000 802,000,000 
      capex
    		-88,000,000 -179,000,000 -132,000,000 -59,000,000 -90,000,000 -153,000,000 -223,000,000 -114,000,000 -77,000,000 -55,000,000 
      free cash flows
    		533,000,000 249,000,000 661,000,000 190,000,000 350,000,000 134,000,000 727,000,000 560,000,000 665,000,000 747,000,000 
      cash flows used in investing activities
    		          
      purchases of property, plant, and equipment
    		-88,000,000 -179,000,000 -132,000,000 -59,000,000 -90,000,000 -153,000,000 -223,000,000 -114,000,000 -77,000,000 -55,000,000 
      other investing activities
    		-2,000,000 12,000,000 6,000,000 3,000,000 5,000,000 1,000,000 -49,000,000    
      net cash flows used in investing activities
    		-90,000,000 -167,000,000 -132,000,000 -56,000,000 -85,000,000 -152,000,000 -265,000,000 -105,000,000 -77,000,000 -41,000,000 
      cash flows used in financing activities
    		          
      (repayments of) proceeds from commercial paper program, net of issuance cost
    		          
      proceeds from issuance of senior notes, net of issuance cost
    		      0 0   
      repayment of senior notes
    		0 -750,000,000         
      dividends paid
    		-393,000,000 -392,000,000 -393,000,000 -393,000,000 -383,000,000 -383,000,000 -383,000,000    
      purchase of treasury stock
    		-64,000,000 -63,000,000         
      other financing activities
    		56,000,000 27,000,000 35,000,000 45,000,000 -5,000,000 -12,000,000 -77,000,000    
      net cash flows used in financing activities
    		-548,000,000 -310,000,000 -587,000,000 -162,000,000   -383,000,000 -726,000,000   
      effect of exchange rate changes on cash and cash equivalents
    		30,000,000 36,000,000 -61,000,000 12,000,000   18,000,000 -12,000,000   
      cash and cash equivalents, beginning of period
    		0 1,070,000,000 0 0   0 0   
      net increase in cash and cash equivalents
    		      320,000,000    
      cash and cash equivalents, end of period
    		13,000,000 1,057,000,000 13,000,000 43,000,000   320,000,000 -169,000,000   
      proceeds from commercial paper program, net of issuance cost
    		 868,000,000 -101,000,000 208,000,000 -110,000,000 160,000,000 77,000,000 -245,000,000   
      net decrease in cash and cash equivalents
    		 -13,000,000         
      losses (gains) on investments
    		          
      transfer of funds to j&j pursuant to the facility agreement
    		      0 0   
      proceeds from j&j upon repayment of the facility agreement
    		      0 0   
      (costs associated with) proceeds from sale of assets
    		          
      proceeds from (payments of) loans and notes payables
    		  -7,000,000 1,000,000       
      proceeds from kenvue ipo
    		      0 0   
      distribution to j&j in connection with the separation
    		      0 0   
      net transfers to j&j
    		          
      supplemental disclosures of cash flow information
    		          
      net cash paid for income taxes
    		          
      cash paid for interest
    		          
      employee related obligations
    		   -2,000,000 2,000,000 5,000,000   -6,000,000 10,000,000 
      proceeds from sale of assets
    		      7,000,000 0 0 14,000,000 
      purchases of treasury shares
    		   -23,000,000 0 -91,000,000     
      impairments
    		     99,000,000     
      cash flows (used in) from financing activities
    		          
      payments of loans and notes payables
    		          
      net transfers from (to) j&j
    		          
      net cash flows (used in) from financing activities
    		     -326,000,000     
      effect of exchange rate changes on cash and cash equivalents and restricted cash
    		     -36,000,000    6,000,000 
      cash and cash equivalents and restricted cash, beginning of period
    		     1,382,000,000    1,231,000,000 
      net increase in cash and cash equivalents and restricted cash
    		     -227,000,000    8,155,000,000 
      cash and cash equivalents and restricted cash, end of period
    		     1,155,000,000    9,386,000,000 
      accounts payable
    		      159,000,000 -98,000,000 383,000,000 -54,000,000 
      accrued liabilities
    		      340,000,000 -52,000,000 724,000,000 52,000,000 
      cash flows from (used in) financing activities
    		          
      (payments of) proceeds from loans and notes payables
    		          
      net transfer from (to) j&j
    		          
      (proceeds from) payments of loans and notes payable
    		          
      net transfer to j&j
    		          
      other investing
    		          
      (payments of) proceeds from loans and notes payable
    		        -2,000,000 -12,000,000 
      net transfer to the parent
    		        12,000,000 -286,000,000 
      other financing
    		          
      proceeds from long-term debt, net of issuance costs
    		         7,686,000,000 
      net cash flows from (used in) financing activities
    		         7,388,000,000 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.